Giglio, Rosaria Vincenza
 Distribuzione geografica
Continente #
NA - Nord America 6.020
EU - Europa 4.359
AS - Asia 3.236
SA - Sud America 600
AF - Africa 96
OC - Oceania 26
Continente sconosciuto - Info sul continente non disponibili 3
Totale 14.340
Nazione #
US - Stati Uniti d'America 5.903
IT - Italia 1.842
SG - Singapore 1.241
RU - Federazione Russa 1.025
CN - Cina 715
BR - Brasile 464
VN - Vietnam 365
HK - Hong Kong 324
DE - Germania 267
PL - Polonia 253
FR - Francia 201
GB - Regno Unito 178
FI - Finlandia 156
JP - Giappone 106
BD - Bangladesh 93
IE - Irlanda 82
IN - India 74
CA - Canada 59
SE - Svezia 58
KR - Corea 49
AR - Argentina 44
IQ - Iraq 41
NL - Olanda 41
TR - Turchia 41
MX - Messico 38
ES - Italia 37
AT - Austria 36
RO - Romania 36
UA - Ucraina 36
ID - Indonesia 24
PK - Pakistan 22
UZ - Uzbekistan 20
EG - Egitto 19
AU - Australia 18
BE - Belgio 18
IR - Iran 17
CZ - Repubblica Ceca 16
ZA - Sudafrica 16
CO - Colombia 15
EC - Ecuador 15
MA - Marocco 15
TH - Thailandia 15
AE - Emirati Arabi Uniti 14
VE - Venezuela 14
BG - Bulgaria 13
CL - Cile 13
CH - Svizzera 12
NP - Nepal 12
IL - Israele 10
LT - Lituania 10
MY - Malesia 10
PY - Paraguay 10
BO - Bolivia 9
PH - Filippine 9
SA - Arabia Saudita 9
KE - Kenya 8
NZ - Nuova Zelanda 8
PE - Perù 8
TN - Tunisia 8
DK - Danimarca 7
GR - Grecia 7
CI - Costa d'Avorio 6
DZ - Algeria 6
UY - Uruguay 6
AL - Albania 5
AZ - Azerbaigian 5
DO - Repubblica Dominicana 4
ET - Etiopia 4
PT - Portogallo 4
RS - Serbia 4
GT - Guatemala 3
JM - Giamaica 3
JO - Giordania 3
KZ - Kazakistan 3
NG - Nigeria 3
TW - Taiwan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
EE - Estonia 2
GY - Guiana 2
HN - Honduras 2
HU - Ungheria 2
LU - Lussemburgo 2
ME - Montenegro 2
NI - Nicaragua 2
OM - Oman 2
PA - Panama 2
PR - Porto Rico 2
SD - Sudan 2
SN - Senegal 2
SY - Repubblica araba siriana 2
AO - Angola 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CG - Congo 1
CR - Costa Rica 1
CV - Capo Verde 1
CY - Cipro 1
DM - Dominica 1
EU - Europa 1
Totale 14.326
Città #
Singapore 844
Ashburn 790
Fairfield 493
Chandler 477
San Jose 383
Hong Kong 308
Palermo 277
Wilmington 224
Zgierz 210
Houston 198
Moscow 196
Seattle 196
Council Bluffs 177
Woodbridge 177
Cambridge 176
Beijing 149
Los Angeles 137
New York 124
Rome 121
Ann Arbor 120
Ho Chi Minh City 111
Medford 101
Des Moines 100
Tokyo 97
Dallas 95
Lauterbourg 95
Milan 84
Hefei 77
Altamura 76
Dublin 76
Santa Clara 74
Helsinki 70
Princeton 66
Hanoi 65
Chicago 64
San Diego 63
Lawrence 62
The Dalles 59
Frankfurt am Main 54
Buffalo 47
São Paulo 47
London 45
Nuremberg 39
Boardman 34
Da Nang 34
Ludwigshafen am Rhein 30
Venice 30
Nanjing 27
Naples 26
Lappeenranta 24
Orem 24
Warsaw 24
Atlanta 23
Florence 23
Montreal 21
Munich 21
Redwood City 21
Falls Church 20
Pune 20
San Paolo di Civitate 20
Brooklyn 18
Columbus 18
Turin 18
Bari 17
Haiphong 17
Jinan 17
Rio de Janeiro 17
Amsterdam 16
Bremen 16
Changsha 16
Memphis 16
Napoli 16
Tashkent 16
Vienna 16
Baghdad 15
Bangkok 15
Boston 15
Brussels 15
Cagliari 15
Denver 15
Miami 15
Alcamo 14
Catania 14
Dearborn 14
Hebei 14
Nanchang 14
Shenyang 14
Ankara 13
Phoenix 13
Falkenstein 12
Johannesburg 12
Padova 12
Paris 12
Poplar 12
Salt Lake City 12
Tianjin 12
Verona 12
Wroclaw 12
Al Mansurah 11
Genoa 11
Totale 8.445
Nome #
PROBIOTICI E TERAPIA CONVENZIONALE: NUOVE FRONTIERE NELLA GESTIONE DELLE MANIFESTAZIONI ARTICOLARI DELLE MALATTIE INFIAMMATORIE INTESTINALI (IBD) 835
Bergamot reduces plasma lipids, atherogenic small dense LDL, and subclinical atherosclerosis in subjects with moderate hypercholesterolemia: A 6 months prospective study 301
Monocyte distribution width (MDW) as a screening tool for sepsis in the Emergency Department 283
Effects of Chitosan on Plasma Lipids and Lipoproteins: A 4-Month Prospective Pilot Study 251
The Role of Nutraceuticals in Statin Intolerant Patients 244
Liraglutide Reduces Oxidative Stress And Restores Heme Oxygenase-1 And Ghrelin Levels In Patients With Type 2 Diabetes: a prospective pilot study. 227
A new tool for sepsis screening in the Emergency Department 221
Serum low density lipoprotein subclasses in asthma 220
Liraglutide increases serum levels of microRNA27b,-130a and-210 in patients with type 2 diabetes mellitus: A novel epigenetic effect 217
Exenatide once-weekly improves metabolic parameters, endothelial dysfunction and carotid intima-media thickness in patients with type-2 diabetes: An 8-month prospective study 214
Management of Statin Intolerance in 2018: Still More Questions Than Answers 211
Effect of a Natural Supplement Containing Curcuma Longa, Guggul, and Chlorogenic Acid in Patients with Metabolic Syndrome 210
The Prevalence of NAFLD and Fibrosis in Bariatric Surgery Patients and the Reliability of Noninvasive Diagnostic Methods 201
Liraglutide improves carotid intima-media thickness in patients with type-2 diabetes and non-alcoholic fatty liver disease: an 8-month prospective pilot study 197
Daily use of extra virgin olive oil with high oleocanthal concentration reduced body weight, waist circumference, alanine transaminase, inflammatory cytokines and hepatic steatosis in subjects with the metabolic syndrome: A 2-month intervention study 197
The effect of bergamot on dyslipidemia 190
Gli effetti extraglicemici di liraglutide: Focus sui marker cardiometabolici 185
Liraglutide improves metabolic parameters and carotid intima-media thickness in diabetic patients with the metabolic syndrome: An 18-month prospective study 184
Diagnostic accuracy of cerebrospinal fluid biomarkers measured by chemiluminescent enzyme immunoassay for Alzheimer disease diagnosis 182
Reference interval of monocyte distribution width (MDW) in healthy blood donors 175
A Nutraceutical Containing Chlorogenic Acid and Luteolin Improves Cardiometabolic Parameters in Subjects with Pre-Obesity: A 6-Month Randomized, Double-Blind, Placebo-Controlled Study 173
Impact of Mycobacterium tuberculosis Infection on Human B Cell Compartment and Antibody Responses 172
Biomarkers Related to Synaptic Dysfunction to Discriminate Alzheimer's Disease from Other Neurological Disorders 168
The effects of liraglutide on glucose, inflammatory markers and lipoprotein metabolism: current knowledge and future perspectives. 168
Lipid subclasses profiles and oxidative stress in aggressive periodontitis before and after treatment 165
Preliminary results of citraves™ effects on low density lipoprotein cholesterol and waist circumference in healthy subjects after 12 weeks: A pilot open-label study 164
Comparison of a rapid immunochromatographic test with a chemiluminescence immunoassay for detection of anti-SARS-CoV-2 IgM and IgG 163
Effect of liraglutide on carotid intima-media thickness in patients with type-2 diabetes: a 4-month prospective study 162
Pasta Supplemented with Opuntia ficus-indica Extract Improves Metabolic Parameters and Reduces Atherogenic Small Dense Low-Density Lipoproteins in Patients with Risk Factors for the Metabolic Syndrome: A Four-Week Intervention Study 162
Prognostic Role of CSF β-amyloid 1-42/1-40 Ratio in Patients Affected by Amyotrophic Lateral Sclerosis 162
Hepatic and circulating levels of PCSK9 in morbidly obese patients: Relation with severity of liver steatosis 161
Comparative analysis of biochip mosaic-based indirect immunofluorescence with enzyme-linked immunosorbent assay for diagnosing myasthenia gravis 161
Time-dependent stability of monocyte distribution width (MDW) 159
Nutraceuticals as an important part of combination therapy in dyslipidaemia 157
Serum lipoproteins are not associated with the severity of asthma 156
Clinical Utility of Midregional Proadrenomedullin in Patients with COVID-19 153
Evaluation of anti-sars-cov-2 s-rbd igg antibodies after covid-19 mrna bnt162b2 vaccine 153
Evaluation of Alpha-Synuclein Cerebrospinal Fluid Levels in Several Neurological Disorders 148
Presepsin and Midregional Proadrenomedullin in Pediatric Oncologic Patients with Febrile Neutropenia 148
Advances in pharmacological treatment of type 1 diabetes during pregnancy 147
COVID-19 and Alzheimer's Disease 146
Monocyte distribution width (MDW) as a reliable biomarker for urosepsis 143
Effects of Liraglutide on Carotid Intima-Media Thickness in Patients with Type-2 Diabetes and Non-Alcoholic Fatty Liver Disease: An 8-Month Prospective Pilot Study 143
NUOVE STRATEGIE TERAPEUTICHE E DIAGNOSTICHE PER IL MANAGEMENT DEL RISCHIO CARDIO-METABOLICO IN PAZIENTI CON NAFLD CON O SENZA DIABETE MELLITO TIPO 2 143
Establishing sex- and age-related reference intervals of serum glial fibrillary acid protein measured by the fully automated lumipulse system 142
A novel beneficial effect of liraglutide: the reduction in subclinical atherosclerosis in patients with type-2 diabetes. 140
FIBROSIS DIAGNOSTIC SCORES VALIDATION IN OBESE PATIENTS WITH NON-ALCOHOLIC LIVER DISEASE 140
Vitamin D and Multiple Sclerosis: An Open-Ended Story 139
Gestational Diabetes and the Metabolic Syndrome: Can Obesity and Small, Dense Low Density Lipoproteins Be Key Mediators Of This Association? 135
The Value of a Complete Blood Count (CBC) for Sepsis Diagnosis and Prognosis 135
Liraglutide improves carotid intima-media thickness in patients with type 2 diabetes and non-alcoholic fatty liver disease: An 8-month prospective pilot study 132
The role of vitamin d as a biomarker in alzheimer’s disease 132
Foxp3 and gata3 polymorphisms, vitamin d3 and multiple sclerosis 132
Tau protein as a diagnostic and prognostic biomarker in amyotrophic lateral sclerosis 126
Serum Vitamin D as a Biomarker in Autoimmune, Psychiatric and Neurodegenerative Diseases 126
Natural approaches in metabolic syndrome management 125
Effects of liraglutide on plasma ghrelin concentrations and oxidative stress in patients with type 2 diabetes: a 2-month prospective pilot study. 119
The Role of Killer Ig-like Receptors in Diseases from A to Z 116
Monocyte distribution width as a biomarker of sepsis in the intensive care unit: A pilot study 115
Diabetes and colorectal cancer risk: A new look at molecular mechanisms and potential role of novel antidiabetic agents 115
Monocyte distribution width (MDW) kinetic for monitoring sepsis in intensive care unit 114
Independent validation of sepsis index for sepsis screening in the emergency department 114
Monocyte Distribution Width (MDW) as a biomarker of sepsis: An evidenced-based laboratory medicine approach 113
The role of serum free light chain as biomarker of Myasthenia Gravis 112
Outcome predictors in SARS-CoV-2 disease (COVID-19): The prominent role of IL-6 levels and an IL-6 gene polymorphism in a western Sicilian population 111
Evaluation of core Biomarkers of Alzheimer’s disease in saliva and plasma measured by chemiluminescent enzyme immunoassays on a fully automated platform 111
Future perspectives of the pharmacological management of diabetic dyslipidemia 110
The Role of TAR DNA Binding Protein 43 (TDP-43) as a CandiDate Biomarker of Amyotrophic Lateral Sclerosis: A Systematic Review and Meta-Analysis 109
An Update on the Current and Emerging Use of Thiazolidinediones for Type 2 Diabetes 107
Novel therapeutical approaches to managing atherosclerotic risk 107
Polyphenols: Potential use in the prevention and treatment of cardiovascular diseases 105
Dyslipidemias 104
Monocyte distribution width kinetic after surgery 104
Recent Updates and Advances in the Use of Glycated Albumin for the Diagnosis and Monitoring of Diabetes and Renal, Cerebro- and Cardio-Metabolic Diseases 103
Validation of monocyte distribution width decisional cutoff for sepsis detection in the acute setting 102
Microglial Activation and Priming in Alzheimer’s Disease: State of the Art and Future Perspectives 100
Monocyte distribution width (MDW) as a screening tool for early detecting sepsis: a systematic review and meta-analysis 100
Preliminary reference intervals of Glycated Albumin in healthy Caucasian pregnant women 99
Neurogranin as a Reliable Biomarker for Synaptic Dysfunction in Alzheimer’s Disease 99
Liraglutide Improved Cardiometabolic Parameters More in Obese than in Non-obese Patients with Type 2 Diabetes: A Real-World 18-Month Prospective Study 98
Pharmacotherapy for gestational diabetes 97
Effect of Semaglutide on Subclinical Atherosclerosis and Cardiometabolic Compensation: A Real-World Study in Patients with Type 2 Diabetes 94
Circulating histones contribute to monocyte and MDW alterations as common mediators in classical and COVID-19 sepsis 94
Advances in the Pharmacological Management of Diabetic Nephropathy: A 2022 International Update 94
Prevalence and heterogeneity of antinuclear antibody patterns in adult Italian patients with autoimmune liver diseases: Our experience 93
Validation of glycated albumin reference interval in healthy Caucasian pregnant women 93
Role of Multiple Vitamin D-Related Polymorphisms in Multiple Sclerosis Severity: Preliminary Findings 93
Biomarkers of Nutritional Status 92
Thrombocytopenia and hyperinflammation are induced by extracellular histones circulating in blood 91
Novel molecular markers of cardiovascular disease risk in type 2 diabetes mellitus 90
Evaluation of the analytical performance of three chemiluminescence serological assays for detecting anti-SARS-CoV-2 antibodies 89
Pharmacotherapy for gestational diabetes mellitus: still insulin, or what about sulfonylureas? 86
Liraglutide Reduces Carotid Intima-Media Thickness by Reducing Small Dense Low-Density Lipoproteins in a Real-World Setting of Patients with Type 2 Diabetes: A Novel Anti-Atherogenic Effect 77
Prostate health index (PHI) as a reliable biomarker for prostate cancer: a systematic review and meta-analysis 73
Experimental and Emerging Free Fatty Acid Receptor Agonists for the Treatment of Type 2 Diabetes 72
Metabolic dysfunction-associated fatty liver disease: current therapeutic strategies 70
Genetic and Epigenetic Biomarkers For Diagnosis, Prognosis and Treatment Of Metabolic Syndrome 66
Urinary urodilatin levels in patients with renal salt wasting syndrome as a possible new diagnostic marker. A pilot study 66
Evaluating the Impact of Novel Incretin Therapies on Cardiovascular Outcomes in Type 2 Diabetes: An Early Systematic Review. 64
Longitudinal analysis of anti-SARS-CoV-2 S-RBD IgG antibodies before and after the third dose of the BNT162b2 vaccine 64
Totale 14.571
Categoria #
all - tutte 58.616
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 58.616


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202174 0 0 0 0 0 0 0 0 0 0 0 74
2021/20221.201 64 126 124 52 44 76 50 118 107 153 115 172
2022/20231.793 135 278 56 172 143 276 137 153 199 50 112 82
2023/2024976 39 97 80 68 62 156 170 55 39 49 49 112
2024/20252.239 51 189 124 181 91 112 201 128 155 242 298 467
2025/20266.264 451 213 477 654 710 825 930 645 569 466 297 27
Totale 14.987